1300736-25-7

Upstream product

• 1300031-61-1 [3-(3,5-dimethyl-4-isoxazolyl)-4-(methyloxy)phenyl]amine 
• 1300031-62-2 3,5-dimethyl-4-[2-(methyloxy)-5-nitrophenyl]isoxazole 
• 16114-47-9 3,5-dimethylisoxazole-4-boronic acid 
• 5399-03-1 2-iodo-1-methoxy-4-nitrobenzene 
• 1300031-65-5 4-chloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-3-nitroquinoline 
• 1300031-66-6 7-(3,5-dimethyl-4-isoxazolyl)-6-(methyloxy)-3-nitro-4-quinolinol 
• 1300031-63-3 7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-N⁴-((R)-1-phenylethyl)quinoline-3,4-diamine 
• 6160-65-2 1,1'-Thiocarbonyldiimidazole 
• 1300031-64-4 7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-3-nitro-N-((R)-1-phenylethyl)quinolin-4-amine 

Relevant academic research and scientific papers

QUINOLINE DERIVATIVES AS BROMODOMAIN INHIBITORS

Provided is a novel quinoline derivative inhibiting the bromodomain and extra terminal domain (BET) proteins, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of a precancerous transformation or a cancer.

Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors

Novel compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

IMIDAZO [4, 5-C] QUINOLINE DERIVATES AS BROMODOMAIN INHIBITORS

Novel compounds of Formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.